Gufic Biosciences Files SEBI Compliance Certificate for Q3 FY26
Gufic Biosciences Limited submitted a SEBI compliance certificate for Q3 FY26. The company's RTA, MUFG Intime India, confirmed processing of dematerialized securities and no shareholder requests during the quarter ended December 31, 2025.
This is a standard regulatory filing confirming compliance with SEBI regulations regarding dematerialization of shares. It does not introduce new material information that would impact the company's stock or business operations.
The announcement is a routine compliance filing and does not contain any new financial information or significant corporate actions that would indicate a positive or negative sentiment.
Gufic Biosciences Limited has submitted a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ending December 31, 2025. The certificate was received from M/s. MUFG Intime India Private Limited, the company's Registrar and Share Transfer Agent (RTA).
The RTA confirmed that securities received from depository participants for dematerialization during the quarter were processed and confirmed to the depositories. They also confirmed that the securities were listed on the stock exchanges where the company's existing securities are traded. The security certificates received for dematerialization were verified, mutilated, cancelled, and the depositories were substituted in the register of members as the registered owner within the stipulated timelines.
MUFG Intime India Private Limited further stated that no requests were received from shareholders during the quarter ended December 31, 2025, and the certificate was issued for compliance purposes. Ami Shah, Company Secretary and Compliance Officer, signed the submission on behalf of Gufic Biosciences Limited.
What to do with a filing like this
Gufic Biosciences Limited filed this with the NSE as a statutory disclosure, categorised under sebi compliance filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Gufic Biosciences Limited. Read the original for the full detail.